A detailed history of Rakuten Investment Management, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Rakuten Investment Management, Inc. holds 3,263 shares of CRL stock, worth $453,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,263
Holding current value
$453,198
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$150.52 - $190.14 $491,146 - $620,426
3,263 New
3,263 $491,000
Q3 2024

May 15, 2025

BUY
$187.96 - $245.29 $137,586 - $179,552
732 Added 33.41%
2,923 $575,000
Q2 2024

May 15, 2025

BUY
$206.39 - $268.73 $167,588 - $218,208
812 Added 58.88%
2,191 $452,000
Q1 2024

May 15, 2025

BUY
$203.52 - $273.43 $254,807 - $342,334
1,252 Added 985.83%
1,379 $373,000
Q4 2023

May 15, 2025

SELL
$164.52 - $238.84 $515,934 - $749,002
-3,136 Reduced 96.11%
127 $30,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.06B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Rakuten Investment Management, Inc. Portfolio

Follow Rakuten Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Investment Management, Inc. with notifications on news.